California State Teachers Retirement System Gritstone Bio, Inc. Transaction History

California State Teachers Retirement System

$84.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.96 - $2.9 $10,546 - $15,604	-5,381 Reduced 37.25%	9,065 $23,000
Q4 2023 Feb 13, 2024	SELL	$1.28 - $2.85 $6,297 - $14,022	-4,920 Reduced 25.41%	14,446 $29,000
Q3 2023 Nov 14, 2023	SELL	$1.19 - $2.26 $11,697 - $22,215	-9,830 Reduced 33.67%	19,366 $33,000
Q2 2023 Aug 21, 2023	BUY	$1.66 - $3.03 $48,465 - $88,463	29,196 New	29,196 $56,000
Q2 2022 Aug 15, 2022	SELL	$1.77 - $4.34 $32,415 - $79,482	-18,314 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.03 - $12.19 $20,266 - $61,303	-5,029 Reduced 21.54%	18,314 $75,000
Q4 2021 Feb 15, 2022	BUY	$8.76 - $13.71 $13,630 - $21,332	1,556 Added 7.14%	23,343 $300,000
Q3 2021 Nov 15, 2021	SELL	$6.41 - $13.54 $217,222 - $458,843	-33,888 Reduced 60.87%	21,787 $235,000
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $83,600 - $104,886	10,283 Added 22.65%	55,675 $508,000
Q1 2021 May 18, 2021	BUY	$4.07 - $27.11 $2,389 - $15,913	587 Added 1.31%	45,392 $428,000
Q2 2020 Aug 17, 2020	BUY	$5.69 - $8.17 $31,454 - $45,163	5,528 Added 14.07%	44,805 $298,000
Q1 2020 May 13, 2020	BUY	$5.47 - $11.3 $2,428 - $5,017	444 Added 1.14%	39,277 $229,000
Q3 2019 Nov 15, 2019	BUY	$8.45 - $12.28 $3,920 - $5,697	464 Added 1.21%	38,833 $335,000
Q2 2019 Aug 14, 2019	BUY	$9.2 - $15.7 $253,377 - $432,393	27,541 Added 254.35%	38,369 $427,000
Q1 2019 May 09, 2019	SELL	$9.97 - $18.96 $16,919 - $32,175	-1,697 Reduced 13.55%	10,828 $144,000
Q4 2018 Feb 13, 2019	BUY	$11.61 - $31.1 $145,415 - $389,527	12,525 New	12,525 $194,000

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Account